The strategic direction of the IGC is set and driven by the IGC Board of Directors, the Scientific Advisory Board, and the Ethics Committee together with the Calouste Gulbenkian Foundation.
Board of Directors
Scientific Advisory Board
The Scientific Advisory Board oversees the scientific progress, graduate programmes, recruitment and overall performance of staff and research groups, advising the Board of the Gulbenkian Foundation on all matters related to the mission of the Institute.
Herbert Jaeckle, President
Anthony Hyman, Vice-President
Joe Bury (VIB, Flandres, Belgium)
Leslie Vosshall (Rockefeller University, New York, USA)
Luis Serrano, (Centre for Genomic Regulation, Barcelona, Spain)
Nancy Moran (University of Texas, Austin, USA)
Martin Raff (University College Londres, UK)
Akiko Iwasaki (Yale University, New Haven, USA)
Patrick Cramer (Max Planck Institute for Biophysical Chemistry, Gottingen, Germany)
The Ethics Committee reviews all research projects involving humans and animals to ensure that full consideration has been given to animal welfare and the ethical implications of the research. The Ethics Committee is an interdisciplinary body made up of 5 members and 4 co-opted members of whom three are laypersons and five are external to the IGC.
Tânia Carvalho, PhD, DVM, President
Carlos Penha-Gonçalves, PhD, DVM – Instituto Gulbenkian de Ciência
Manuel Rebelo, PhD – Instituto Gulbenkian de Ciência
Miguel Fontes, MD – External Member
Isabel Garcia – External Member
Vera Martins, PhD – Instituto Gulbenkian de Ciência
Maria de Athayde Tavares – Lawyer, External Member
Vasco Trigo – Jornalista – External Member
Ana Cristina Borges, PhD – Instituto Gulbenkian de Ciência